These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis. Merkel PA; Niles JL; Mertz LE; Lehane PB; Pordeli P; Erblang F Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1372-1378. PubMed ID: 32475029 [TBL] [Abstract][Full Text] [Related]
10. [THE MECHANISMS OF ACTION OF RITUXIMAB]. Gil'deeva GN; Kudlai DA; Luk'yanov SV Eksp Klin Farmakol; 2015; 78(12):51-6. PubMed ID: 27051930 [TBL] [Abstract][Full Text] [Related]
11. A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea. Jo JC; Jeon Y; Kim D; Yang DH; Lee WS; Choi YS; Yi JH; Yoon DH; Kong JH; Choe JY; Kim S; Ahn K; Park T; Ju H; Kwon S; Cho SG Expert Opin Biol Ther; 2023; 23(8):737-747. PubMed ID: 36757373 [TBL] [Abstract][Full Text] [Related]
12. Rituximab Biosimilar Prevents Poor Outcomes of Microscopic Polyangiitis and Granulomatosis with Polyangiitis as Effectively as Rituximab Originator. Kwon HC; Kim MK; Song JJ; Park YB; Lee SW Yonsei Med J; 2020 Aug; 61(8):712-719. PubMed ID: 32734735 [TBL] [Abstract][Full Text] [Related]
13. Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis. Borie D; Kremer JM Semin Arthritis Rheum; 2015 Oct; 45(2):163-6. PubMed ID: 26190565 [TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions. Bennett CL; Focosi D; Socal MP; Bian JC; Nabhan C; Hrushesky WJ; Bennett AC; Schoen MW; Berger JR; Armitage JO; Lancet Haematol; 2021 Aug; 8(8):e593-e604. PubMed ID: 34329579 [TBL] [Abstract][Full Text] [Related]
15. Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis. Singer O; McCune WJ Curr Opin Rheumatol; 2017 May; 29(3):248-253. PubMed ID: 28306595 [TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments. Clavel G; Moulignier A; Semerano L Joint Bone Spine; 2017 Dec; 84(6):671-675. PubMed ID: 28323224 [TBL] [Abstract][Full Text] [Related]
17. Progressive multifocal encephalopathy after cyclophosphamide in granulomatosis with polyangiitis (Wegener) patients: case report and review of literature. Pugnet G; Pagnoux C; Bézanahary H; Ly KH; Vidal E; Guillevin L Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S62-4. PubMed ID: 23663683 [TBL] [Abstract][Full Text] [Related]
18. Pharmacovigilance and PML in the oncology setting. Bennett CL Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S13-7. PubMed ID: 22123927 [TBL] [Abstract][Full Text] [Related]
19. Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis. Owczarczyk K; Cascino MD; Holweg C; Tew GW; Ortmann W; Behrens T; Schindler T; Langford CA; St Clair EW; Merkel PA; Spiera R; Seo P; Kallenberg CG; Specks U; Lim N; Stone J; Brunetta P; Prunotto M; JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32841219 [TBL] [Abstract][Full Text] [Related]
20. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study. Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H; Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]